Parasutterella

Last updated

Parasutterella
Scientific classification
Domain:
Bacteria
Phylum:
Pseudomonadota
Class:
Betaproteobacteria
Order:
Burkholderiales
Family:
Sutterellaceae
Genus:
Parasutterella

Nagai et al. 2009
Species

Parasutterella excrementihominis
Parasutterella secunda

Contents

Parasutterella is a genus of Gram-negative, circular/rod-shaped, obligate anaerobic, non-spore forming bacteria from the Pseudomonadota phylum, Betaproteobacteria class and the family Sutterellaceae. [1] [2] Previously, this genus was considered "unculturable," [1] meaning that it could not be characterized through conventional laboratory techniques, such as grow in culture due its unique requirements of anaerobic environment. The genus was initially discovered through 16S rRNA sequencing and bioinformatics analysis (a methodology to analyze the microbiome). By analyzing the sequence similarity, Parasutterella was determined to be related most closely to the genus Sutterella and previously classified in the family Alcaligenaceae.

In 2009, Parasutterella excrementihominis was cultured and characterized. [1] In 2011, another species of Parasutterella, Parasutterella secunda , was discovered, and both Parasutterella and Sutterella species were reclassified under the family Sutterellaceae. [2] (This reclassification occurred due to the similar biochemical potential in the Sutterella and Parasutterella genera different from other genera in the family Alcaligenaceae.) [2] To date, Parasutterella contains two cultured species and numerous uncultured species. Both cultured species were isolated from human feces and are considered to be part of the gut microbiome in a healthy individual. [1] [2] [3]

Characteristics

Parasutterella species are Gram-negative, coccobacilli (circular and rod-shaped), strictly (or obligate) anaerobic, non-motile bacteria. [1] [2] When cultured, colonies from both P. excrementihominis and P. secunda appeared translucent to beige in color, convex and circular in shape, and extremely small in size. [1] [2] Both species do not metabolize glucose, lactate, or succinate or produce indole or short-chain fatty acids. [1] [2] Additionally, these bacteria do not reduce nitrate and are catalase-negative (inability to breakdown hydrogen peroxide into oxygen and water), urease-negative (inability to hydrolyze urea to ammonia and carbon dioxide), and oxidase-negative (inability to use oxygen). [1] [2] However, these bacteria have the following enzymes: arginine dihydrolase, esterase (C4), esterase lipase, naphthol-AS-BI-phosphohydrolase, and alkaline phosphatase. [1] [2] P. excrementihominis can grow in bile, although P. secunda has not been described in terms of this ability. [1] Moreover, P. excrementihominis and P. secunda are unique in terms of sequences and certain biochemical processes. For example, the major respiratory quinone of P. excrementihominis was methylmenaquinone-6 whereas the dominant respiratory quinone for P. secunda is methylmenaquinone-5. [2]

Parasutterella and Sutterella contain several similarities, including sequence homology, inability to grow in an aerobic environment, oxidase- and catalase-negative, and the dominant major quinone of either methylmenaquinone-5 or -6 or menaquinone-5 or -6. Still, Parasutterella species can be differentiated from Sutterella species in several ways. For example, colonies from Sutterella tend to appear a little larger and under the microscope, appear as bacilli or rod-shaped bacteria. [1] While both species of Parasutterella do not reduce nitrate, some species from Sutterella have the ability for nitrate reduction. [1] Both P. excrementihominis and P. secunda have the enzyme esterase, whereas no species in Sutterella to date have esterase (C4). [1] Also, the major cellular fatty acids in Parasutterella are different than those associated with Sutterella. [1] [2]

Molecular taxonomy

Parasutterella has been divided into three different groups on the basis of their 16S rRNA sequences: P. excrementihominis, P. secunda, and uncultured bacterium. [2] [4] In the Silva 16S rRNA reference library, each group can then be further divided into various accession numbers or operational taxonomical units (OTUs) due to slight differences in sequence. [4] P. excrementihominis has six different OTUs or strains, whereas P. secunda has three different OTUs. [4]

Associations in human health

Parasutterella is still a relatively new genus and has been exclusively published in regards to literature on the intestinal microbiome (with the exception of the first two taxonomical papers on the discovery of P. excrementihominis and P. secunda). Both P. excrementihominis and P. secunda were isolated from fecal samples from healthy Japanese individuals and have been found to be part of the intestinal microbiome in the United States. [1] [2] In a study that examined the effect of introducing and reversing diet-induced obesity on the gut microbiome and metabolism in mice, Parasutterella was decreased in mice with diet-induced obesity and increased in controls and reversal of the high fat diet with a healthier alternative (normal chow). [5] Other studies have shown increases of Parasutterella with sugar [6] and alcohol consumption. [7] Additional microbiome studies have associated increased abundance of Parasutterella with dysbiosis, or a lack of diversity in the microbial composition typically in the gut. [8] [9] (Dysbiosis has been correlated with intestinal and metabolic dysfunction and several diseases, including inflammatory bowel diseases and obesity.) [10] For example, Parasutterella was increased in the submucosa in the ileum of the small intestine in individuals with Crohn's disease [8] and hypertriglyceridemia-related acute necrotizing pancreatitis in rats. [9] More research is needed to further explore the role of Parasutterella species as a part of the healthy gut microbiome and in microbial dysbiosis.

See also

Related Research Articles

<span class="mw-page-title-main">Human microbiome</span> Microorganisms in or on human skin and biofluids

The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Though micro-animals can also live on the human body, they are typically excluded from this definition. In the context of genomics, the term human microbiome is sometimes used to refer to the collective genomes of resident microorganisms; however, the term human metagenome has the same meaning.

<span class="mw-page-title-main">Bacillota</span> Phylum of bacteria

The Bacillota are a phylum of bacteria, most of which have gram-positive cell wall structure. The renaming of phyla such as Firmicutes in 2021 remains controversial among microbiologists, many of whom continue to use the earlier names of long standing in the literature.

<span class="mw-page-title-main">Gut microbiota</span> Community of microorganisms in the gut

Gut microbiota, gut microbiome, or gut flora, are the microorganisms, including bacteria, archaea, fungi, and viruses, that live in the digestive tracts of animals. The gastrointestinal metagenome is the aggregate of all the genomes of the gut microbiota. The gut is the main location of the human microbiome. The gut microbiota has broad impacts, including effects on colonization, resistance to pathogens, maintaining the intestinal epithelium, metabolizing dietary and pharmaceutical compounds, controlling immune function, and even behavior through the gut–brain axis.

<i>Bacteroides</i> Genus of bacteria

Bacteroides is a genus of Gram-negative, obligate anaerobic bacteria. Bacteroides species are non endospore-forming bacilli, and may be either motile or nonmotile, depending on the species. The DNA base composition is 40–48% GC. Unusual in bacterial organisms, Bacteroides membranes contain sphingolipids. They also contain meso-diaminopimelic acid in their peptidoglycan layer.

<span class="mw-page-title-main">Paneth cell</span> Anti-microbial epithelial cell of the small intestine

Paneth cells are cells in the small intestine epithelium, alongside goblet cells, enterocytes, and enteroendocrine cells. Some can also be found in the cecum and appendix. They are located below the intestinal stem cells in the intestinal glands and the large eosinophilic refractile granules that occupy most of their cytoplasm.

<span class="mw-page-title-main">Germ-free animal</span> Multi-cellular organisms that have no microorganisms living in or on them

Germ-free organisms are multi-cellular organisms that have no microorganisms living in or on them. Such organisms are raised using various methods to control their exposure to viral, bacterial or parasitic agents. When known microbiota are introduced to a germ-free organism, it usually is referred to as a gnotobiotic organism, however technically speaking, germ-free organisms are also gnotobiotic because the status of their microbial community is known. Due to lacking a microbiome, many germ-free organisms exhibit health deficits such as defects in the immune system and difficulties with energy acquisition. Typically germ-free organisms are used in the study of a microbiome where careful control of outside contaminants is required.

Dysbiosis is characterized by a disruption to the microbiome resulting in an imbalance in the microbiota, changes in their functional composition and metabolic activities, or a shift in their local distribution. For example, a part of the human microbiota such as the skin flora, gut flora, or vaginal flora, can become deranged, with normally dominating species underrepresented and normally outcompeted or contained species increasing to fill the void. Dysbiosis is most commonly reported as a condition in the gastrointestinal tract.

Microecology means microbial ecology or ecology of a microhabitat. In humans, gut microecology is the study of the microbial ecology of the human gut which includes gut microbiota composition, its metabolic activity, and the interactions between the microbiota, the host, and the environment. Research in human gut microecology is important because the microbiome can have profound effects on human health. The microbiome is known to influence the immune system, digestion, and metabolism, and is thought to play a role in a variety of diseases, including diabetes, obesity, inflammatory bowel disease, and cancer. Studying the microbiome can help us better understand these diseases and develop treatments.

Rikenellaceae is a family of Gram-negative bacteria described by Noel R. Krieg in 2015. It contains nine genera, five of which are validly published by the International Code of Nomenclature of Prokaryotes. Bacteria with 16S ribosomal RNA highly similar to the Rikenella genus, as compared to the larger taxonomic order Bacteroidales, are classified in this family.

Jeffrey Ivan Gordon is a biologist and the Dr. Robert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis. He is internationally known for his research on gastrointestinal development and how gut microbial communities affect normal intestinal function, shape various aspects of human physiology including our nutritional status, and affect predisposition to diseases. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the Institute of Medicine of the National Academies, and the American Philosophical Society.

<span class="mw-page-title-main">Microbial symbiosis and immunity</span>

Long-term close-knit interactions between symbiotic microbes and their host can alter host immune system responses to other microorganisms, including pathogens, and are required to maintain proper homeostasis. The immune system is a host defense system consisting of anatomical physical barriers as well as physiological and cellular responses, which protect the host against harmful microorganisms while limiting host responses to harmless symbionts. Humans are home to 1013 to 1014 bacteria, roughly equivalent to the number of human cells, and while these bacteria can be pathogenic to their host most of them are mutually beneficial to both the host and bacteria.

<span class="mw-page-title-main">Microbiota</span> Community of microorganisms

Microbiota are the range of microorganisms that may be commensal, mutualistic, or pathogenic found in and on all multicellular organisms, including plants. Microbiota include bacteria, archaea, protists, fungi, and viruses, and have been found to be crucial for immunologic, hormonal, and metabolic homeostasis of their host.

Faecalibacterium is a genus of bacteria. The genus contains several species including Faecalibacterium prausnitzii, Faecalibacterium butyricigenerans, Faecalibacterium longum, Faecalibacterium duncaniae, Faecalibacterium hattorii, and Faecalibacterium gallinarum. Its first known species, Faecalibacterium prausnitzii is gram-positive, mesophilic, rod-shaped, and anaerobic, and is one of the most abundant and important commensal bacteria of the human gut microbiota. It is non-spore forming and non-motile. These bacteria produce butyrate and other short-chain fatty acids through the fermentation of dietary fiber. The production of butyrate makes them an important member of the gut microbiota, fighting against inflammation.

Ruminococcus is a genus of bacteria in the class Clostridia. They are anaerobic, Gram-positive gut microbes. One or more species in this genus are found in significant numbers in the human gut microbiota. The type species is R. flavefaciens. As usual, bacteria taxonomy is in flux, with Clostridia being paraphyletic, and some erroneous members of Ruminococcus being reassigned to a new genus Blautia on the basis of 16S rRNA gene sequences.

Sutterella is a genus of Gram-negative, rod-shaped, non-spore-forming, Betaproteobacteria whose species have been isolated from the human gastrointestinal tract as well as canine feces. The genus of the family Sutterellaceae currently encompasses 4 distinct species, though at least 5 additional species have been proposed that do not yet meet International Code of Nomenclature of Prokaryotes (ICNP) standards for classification. Sutterella are frequently referred to as commensal in the context of human hosts, but are associated with inflammation, which has implications for a number of diseases.

<i>Akkermansia muciniphila</i> Species of bacterium

Akkermansia muciniphila is a human intestinal symbiont, isolated from human feces. It is a mucin-degrading bacterium belonging to the genus, Akkermansia, discovered in 2004 by Muriel Derrien and Willem de Vos at Wageningen University of the Netherlands. It belongs to the phylum Verrucomicrobiota and its type strain is MucT. It is under preliminary research for its potential association with metabolic disorders.

<span class="mw-page-title-main">Gut–brain axis</span> Biochemical signaling between the gastrointestinal tract and the central nervous system

The gut–brain axis is the two-way biochemical signaling that takes place between the gastrointestinal tract and the central nervous system (CNS). The "microbiota–gut–brain axis" includes the role of gut microbiota in the biochemical signaling events that take place between the GI tract and the CNS. Broadly defined, the gut–brain axis includes the central nervous system, neuroendocrine system, neuroimmune systems, the hypothalamic–pituitary–adrenal axis, sympathetic and parasympathetic arms of the autonomic nervous system, the enteric nervous system, vagus nerve, and the gut microbiota.

Bacteriotherapy is the purposeful use of bacteria or their products in treating an illness. Forms of bacteriotherapy include the use of probiotics, microorganisms that provide health benefits when consumed; fecal matter transplants (FMT) /intestinal microbiota transplant (IMT), the transfer of gut microorganisms from the fecal matter of healthy donors to recipient patients to restore microbiota; or synbiotics which combine prebiotics, indigestible ingredients that promote growth of beneficial microorganisms, and probiotics. Through these methods, the gut microbiota, the community of 300-500 microorganism species that live in the digestive tract of animals aiding in digestion, energy storage, immune function and protection against pathogens, can be recolonized with favorable bacteria, which in turn has therapeutic effects.

The Human Microbiome Project (HMP), completed in 2012, laid the foundation for further investigation into the role the microbiome plays in overall health and disease. One area of particular interest is the role which delivery mode plays in the development of the infant/neonate microbiome and what potential implications this may have long term. It has been found that infants born via vaginal delivery have microbiomes closely mirroring that of the mother's vaginal microbiome, whereas those born via cesarean section tend to resemble that of the mother's skin. One notable study from 2010 illustrated an abundance of Lactobacillus and other typical vaginal genera in stool samples of infants born via vaginal delivery and an abundance of Staphylococcus and Corynebacterium, commonly found on the skin surfaces, in stool samples of infants born via cesarean section. From these discoveries came the concept of vaginal seeding, also known as microbirthing, which is a procedure whereby vaginal fluids are applied to a new-born child delivered by caesarean section. The idea of vaginal seeding was explored in 2015 after Maria Gloria Dominguez-Bello discovered that birth by caesarean section significantly altered the newborn child's microbiome compared to that of natural birth. The purpose of the technique is to recreate the natural transfer of bacteria that the baby gets during a vaginal birth. It involves placing swabs in the mother's vagina, and then wiping them onto the baby's face, mouth, eyes and skin. Due to the long-drawn nature of studying the impact of vaginal seeding, there are a limited number of studies available that support or refute its use. The evidence suggests that applying microbes from the mother's vaginal canal to the baby after cesarean section may aid in the partial restoration of the infant's natural gut microbiome with an increased likelihood of pathogenic infection to the child via vertical transmission.

<span class="mw-page-title-main">Pharmacomicrobiomics</span>

Pharmacomicrobiomics, proposed by Prof. Marco Candela for the ERC-2009-StG project call, and publicly coined for the first time in 2010 by Rizkallah et al., is defined as the effect of microbiome variations on drug disposition, action, and toxicity. Pharmacomicrobiomics is concerned with the interaction between xenobiotics, or foreign compounds, and the gut microbiome. It is estimated that over 100 trillion prokaryotes representing more than 1000 species reside in the gut. Within the gut, microbes help modulate developmental, immunological and nutrition host functions. The aggregate genome of microbes extends the metabolic capabilities of humans, allowing them to capture nutrients from diverse sources. Namely, through the secretion of enzymes that assist in the metabolism of chemicals foreign to the body, modification of liver and intestinal enzymes, and modulation of the expression of human metabolic genes, microbes can significantly impact the ingestion of xenobiotics.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Nagai, Fumiko; Morotomi, Masami; Sakon, Hiroshi; Tanaka, Ryuichiro (2009). "Parasutterella excrementihominis gen. nov., sp. nov., a member of the family Alcaligenaceae isolated from human faeces". International Journal of Systematic and Evolutionary Microbiology. 59 (7): 1793–1797. doi: 10.1099/ijs.0.002519-0 . PMID   19542131.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 Morotomi, Masami; Nagai, Fumiko; Watanabe, Yohei (2011). "Parasutterella secunda sp. nov., isolated from human faeces and proposal of Sutterellaceae fam. nov. in the order Burkholderiales". International Journal of Systematic and Evolutionary Microbiology. 61 (3): 637–643. doi: 10.1099/ijs.0.023556-0 . PMID   20400667.
  3. ↑ Jeong, Ju-Yong; Park, Hee-Deung; Lee, Kyong-Hee; Weon, Hang-Yeon; Ka, Jong-Ok (2011-08-01). "Microbial community analysis and identification of alternative host-specific fecal indicators in fecal and river water samples using pyrosequencing". The Journal of Microbiology. 49 (4): 585–94. doi:10.1007/s12275-011-0530-6. ISSN   1225-8873. PMID   21887641. S2CID   43413479.
  4. 1 2 3 "Search". www.arb-silva.de. Retrieved 2017-11-30.
  5. ↑ Zhang, Chenhong; Zhang, Menghui; Pang, Xiaoyan; Zhao, Yufeng; Wang, Linghua; Zhao, Liping (October 2012). "Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations". The ISME Journal. 6 (10): 1848–1857. doi:10.1038/ismej.2012.27. ISSN   1751-7370. PMC   3446802 . PMID   22495068.
  6. ↑ Noble, Emily E.; Hsu, Ted M.; Jones, Roshonda B.; Fodor, Anthony A.; Goran, Michael I.; Kanoski, Scott E. (2017-01-01). "Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity". The Journal of Nutrition. 147 (1): 20–28. doi:10.3945/jn.116.238816. ISSN   0022-3166. PMC   5177734 . PMID   27903830.
  7. ↑ Zhang, Xiaoxia; Wang, Hao; Yin, Peipei; Fan, Hang; Sun, Liwei; Liu, Yujun (2017-02-22). "Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice". Lipids in Health and Disease. 16 (1): 44. doi: 10.1186/s12944-017-0431-8 . ISSN   1476-511X. PMC   5322643 . PMID   28228158.
  8. 1 2 Chiodini, Rodrick J.; Dowd, Scot E.; Chamberlin, William M.; Galandiuk, Susan; Davis, Brian; Glassing, Angela (2015-07-29). "Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum". PLOS ONE. 10 (7): e0134382. Bibcode:2015PLoSO..1034382C. doi: 10.1371/journal.pone.0134382 . ISSN   1932-6203. PMC   4519195 . PMID   26222621.
  9. 1 2 Huang, Chunlan; Chen, Jing; Wang, Jingjing; Zhou, Hui; Lu, Yingying; Lou, Lihong; Zheng, Junyuan; Tian, Ling; Wang, Xingpeng (2017). "Dysbiosis of Intestinal Microbiota and Decreased Antimicrobial Peptide Level in Paneth Cells during Hypertriglyceridemia-Related Acute Necrotizing Pancreatitis in Rats". Frontiers in Microbiology. 8: 776. doi: 10.3389/fmicb.2017.00776 . ISSN   1664-302X. PMC   5415626 . PMID   28522995.
  10. ↑ Carding, Simon; Verbeke, Kristin; Vipond, Daniel T.; Corfe, Bernard M.; Owen, Lauren J. (2015). "Dysbiosis of the gut microbiota in disease". Microbial Ecology in Health & Disease. 26: 26191. doi:10.3402/mehd.v26.26191. PMC   4315779 . PMID   25651997.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.